Putative Role of Dihydropyrimidine Dehydrogenase in the Toxic Side Effect of 5-Fluorouracil in Colorectal Cancer Patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Manual of pharmacologic calculations with computer programs
1988 • 1,456 citations
Fluorouracil: biochemistry and pharmacology.
1988 • 825 citations
Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.
1988 • 500 citations
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.
1990 • 443 citations
Population study of dihydropyrimidine dehydrogenase in cancer patients.
1994 • 428 citations
Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy.
1993 • 371 citations
Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.
1995 • 287 citations
Studies on fluorinated pyrimidines. IV. Effects on nucleic acid metabolism in vivo.
1958 • 259 citations
Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil Toxicity
1985 • 254 citations
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.
1992 • 233 citations
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome
1991 • 225 citations
Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.
1996 • 164 citations
Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase
1981 • 137 citations
cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria.
1994 • 121 citations
Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy.
1994 • 104 citations
5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA.
1981 • 103 citations
Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.
1993 • 101 citations
Link between dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells and liver.
1996 • 97 citations
Dihydropyrimidine dehydrogenase activity in cancer patients
1993 • 86 citations
The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts
1982 • 62 citations
Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review).
1994 • 56 citations
Resistance to antimetabolites
1996 • 52 citations
The biology of colorectal cancer. Implications for pretreatment and follow-up management
1993 • 49 citations
Decreased Catabolism of Fluorouracil in Peripheral Blood Mononuclear Cells During Combination Therapy With Fluorouracil, Leucovorin, and Interferon -2a
1992 • 44 citations
The effect of 5-fluorouracil on the synthesis and methylation of low molecular weight nuclear RNA in L1210 cells.
1980 • 43 citations
The effect of 5-fluorouracil on the synthesis of nuclear RNA in L1210 cells in vitro.
1979 • 39 citations
Structure-activity relationship of ligands of dihydrouracil dehydrogenase from mouse liver
1989 • 35 citations
Dihydropyrimidine dehydrogenase deficiency presenting with psychomotor retardation and ocular abnormalities
1994 • 7 citations